Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.
Walker SM, Knight LA, McCavigan AM, Logan GE, Berge V, Sherif A, Pandha H, Warren AY, Davidson C, Uprichard A, Blayney JK, Price B, Jellema GL, Steele CJ, Svindland A, McDade SS, Eden CG, Foster C, Mills IG, Neal DE, Mason MD, Kay EW, Waugh DJ, Harkin DP, Watson RW, Clarke NW, Kennedy RD. Walker SM, et al. Among authors: watson rw. Eur Urol. 2017 Oct;72(4):509-518. doi: 10.1016/j.eururo.2017.03.027. Epub 2017 Apr 10. Eur Urol. 2017. PMID: 28408174 Free article.
Insulin-like growth factor I and prostate cancer.
O'Brien MF, Watson RW, Fitzpatrick JM. O'Brien MF, et al. Among authors: watson rw. Urology. 2001 Jul;58(1):1-7. doi: 10.1016/s0090-4295(01)01004-4. Urology. 2001. PMID: 11445469 Review. No abstract available.
Patented prostate cancer biomarkers.
Murphy L, Watson RW. Murphy L, et al. Among authors: watson rw. Nat Rev Urol. 2012 Aug;9(8):464-72. doi: 10.1038/nrurol.2012.130. Epub 2012 Jul 3. Nat Rev Urol. 2012. PMID: 22750955 Review.
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.
Tyekucheva S, Bowden M, Bango C, Giunchi F, Huang Y, Zhou C, Bondi A, Lis R, Van Hemelrijck M, Andrén O, Andersson SO, Watson RW, Pennington S, Finn SP, Martin NE, Stampfer MJ, Parmigiani G, Penney KL, Fiorentino M, Mucci LA, Loda M. Tyekucheva S, et al. Among authors: watson rw. Nat Commun. 2017 Sep 4;8(1):420. doi: 10.1038/s41467-017-00460-4. Nat Commun. 2017. PMID: 28871082 Free PMC article.
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer.
Murphy K, Murphy BT, Boyce S, Flynn L, Gilgunn S, O'Rourke CJ, Rooney C, Stöckmann H, Walsh AL, Finn S, O'Kennedy RJ, O'Leary J, Pennington SR, Perry AS, Rudd PM, Saldova R, Sheils O, Shields DC, Watson RW. Murphy K, et al. Among authors: watson rw. Mol Oncol. 2018 Sep;12(9):1513-1525. doi: 10.1002/1878-0261.12348. Epub 2018 Aug 7. Mol Oncol. 2018. PMID: 29927052 Free PMC article.
Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue.
Medlow PW, Steele CJ, McCavigan AM, Reardon W, Brown CM, Lambe SM, Ishiy FAA, Walker SM, Logan GE, Raji OY, Berge V, Katz B, Kay EW, Sheehan K, Watson RW, Harkin DP, Kennedy RD, Knight LA. Medlow PW, et al. Among authors: watson rw. BMC Med Genomics. 2018 Dec 27;11(1):125. doi: 10.1186/s12920-018-0442-y. BMC Med Genomics. 2018. PMID: 30591067 Free PMC article.
237 results